Le cluster United States - United States Food and Drug Administration
| 000066 (1998) | Radioimmunoscintigraphy for prostate cancer. | |
| 000077 (1996) | Monoclonal antibody scan holds promise for prostate cancer staging. | |
| 000067 (1998) | Indium-111 satumomab pendetide: the first FDA-approved monoclonal antibody for tumor imaging. | |
| 000041 (2005) | The role of imaging with (111)In-ibritumomab tiuxetan in the ibritumomab tiuxetan (zevalin) regimen: results from a Zevalin Imaging Registry. | |
| 000052 (2002) | From the Food and Drug Administration. | |
| 000076 (1996) | Radiation absorbed dose from indium-111-CYT-356. | |
| 000114 (1986) | Radiopharmaceutical approved for the labeling of autologous leukocytes. | |
| 000013 (2011) | Photoelectrochemical competitive DNA hybridization assay using semiconductor quantum dot conjugated oligonucleotides. | |
| 000023 (2010) | Competitive multi-immunosensing of pesticides based on the particle manipulation with negative dielectrophoresis. | |
| 000031 (2009) | Chitosan/polyaniline hybrid conducting biopolymer base impedimetric immunosensor to detect Ochratoxin-A. | |
| 000032 (2008) | Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer. | |
| 000047 (2004) | Classification of German white wines with certified brand of origin by multielement quantitation and pattern recognition techniques. | |
| 000078 (1996) | Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo. |
| This area was generated with Dilib version V0.5.76. |  |